Arobella introduces new ultrasound wound therapy
hand piece at SAWC Spring 2013!
Minneapolis, Minn. (May 3, 2013) - Arobella introduces new ultrasound wound therapy hand piece for the Qoustic Wound Therapy System™ platform at SAWC Spring 2013. The new Qoustic Wound Therapy System™, Model AR1000D Series converter hand piece provides quicker and easier turnaround between patients and adds the ability to be steam sterilized for ready use in the sterile field (e.g. operating rooms/theatres and the like).
Debridement is essential for proper wound management, and the Qoustic Qurette™ unique dome-shaped probe puts Ultrasonic Wound Therapy (UWT) to work debriding patients’ wounds, i.e. removing, by direct contact, superficial dead tissue, exudates, and other non-viable matter from healthy tissue. Simpler and easier than ever, the new AR1000D hand piece can treat more patients than ever before and make an even bigger impact on the standard-of-care in treating wounds.
New ultrasound wound therapy hand piece launched!
Minneapolis, Minn. (March 15, 2013) - New ultrasound wound therapy hand piece launched for the Qoustic Wound Therapy System™ platform. The new Qoustic Wound Therapy System™, Model AR1000D Series converter hand piece provides quicker and easier turnaround between patients and adds the ability to be steam sterilized for ready use in the sterile field.
New ultrasound wound therapy arrives at Aurora Health – Fond du Lac
Minneapolis, Minn.(January 23, 2012) - Maria E. Saleh, DPM, MS, of Aurora Health Center (Fond du Lac, WI), who recently completed training on the Qoustic Wound Therapy System™ technology, is already putting this unique Ultrasonic Wound Therapy (UWT) to work debriding patients’ wounds, i.e. removing, by direct contact, superficial dead tissue, exudates, and other non-viable matter from healthy tissue.
When applied to the wound bed, UWT debridement via the Qoustic Qurette™ probe produces deep tissue penetration of ultrasonic energy, and the associated fibrinolytic action cleaves the necrotic slough and biofilm from the underlying viable tissue without removing healthy tissue. The results have translated almost immediately to better wound treatment vectors and better overall outcomes with fewer complications. Dr. Saleh is excited by the possibilities of how this new ultrasonic therapy will change the approach and treatment of all types of wounds and by the opportunity to bring it to her patients.
Debridement is essential for proper wound management as it enhances the proliferative phase activity by removing all foreign material and all contaminated and devitalized tissues from or adjacent to a traumatic or infected area until surrounding healthy tissue is exposed and eliminating necrotic tissue that can act as a medium for biofilm and/or infection on the wound.
This is the seventh Aurora Health facility to use the Qoustic Wound Therapy System device for debriding their patients’ wounds and allowing them to provide statewide coverage. Aurora Health was among the first users nationwide to adopt this exciting technology and consequently advance clinical practice by leveraging UWT in overall wound management.
Russian scientist Eliaz Babaev, Ph.D., developed the ultrasonic Qoustic Wound Therapy System device and its unique dome-shaped Qoustic Qurette™ probe. He is the CEO and President of Arobella Medical, LLC, based in Minnetonka, MN, which manufacturers and markets the device. This new generation of ultrasonic wound treatment is highly effective because it focuses variable power ultrasonic energy directly on the wound bed while debriding and irrigating wound tissue.
About Maria E. Saleh, DPM, MS
As a specialist in podiatric medicine and surgery, Maria E. Saleh, DPM, MS, helps patients resume normal daily activities after foot injury or disease. She has been honored with many awards, including the Gold Award in Dermatology and the Silver Award in Pediatrics.
Please call or contact us to find out how you can bring the Qoustic Wound Therapy System® to your facility and evaluate all of our flexible pricing options.
The Qoustic Wound Therapy System® is specifically designed to maintain sufficient momentum throughout the wound healing process for optimal healing. The Qoustic Wound Therapy System® is an ideal choice for treating a variety of wounds, including:
The Qoustic Wound Therapy System® provides a superior debriding process for both treatment providers and patients. The unique domed shape of the Qoustic Qurette™ gives the treatment provider more control for gentle and selective volumetric removal of necrotic tissue. This state-of-the-art technology targets focused low frequency ultrasonic energy through saline to the wound bed. It is this unique delivery of low frequency ultrasonic energy that optimizes healing while potentially minimizing patient discomfort. Please contact us for more information.
March 15, 2013
New ultrasound wound therapy hand piece launched!
August 26, 2011
Arobella Medical Announces Its Largest International Sale
Join us at these shows:
Pacific Coast Region WOCN 2013 Conference
February 28th - March 03rd
Diabetic Foot Global Conference (DFCon)
March 21st - March 23rd
Los Angeles, CA
American Podiatric Wound Care Association (APWCA) 2013 National Clinical Conference
April 04th - April 07th
The Symposium Advanced Wound Care - Spring (SAWC-Spring)
May 01st - May 05th
All trademarks reserved by their respective holders and do not represent endorsement of this site, company, or its product.